Neurocrine Biosciences, Inc. (NBIX) vs Dr. Reddy's Laboratories Ltd (RDY)
- Neurocrine Biosciences, Inc. NBIX 135.71 −0.91%
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Neurocrine Biosciences, Inc. is the larger, with a market value of $13.9B against $10.7B — 1.3× the size. Neurocrine Biosciences, Inc. trades at the lower P/E: 19.2× against 32.9×. Neurocrine Biosciences, Inc. grew revenue faster over the last twelve months: 34.4% against −11.6%. Neurocrine Biosciences, Inc. has the higher net margin (20.9% vs 9.81%) and the higher return on invested capital (15.0% vs 5.89%). Across the 22 metrics below, Neurocrine Biosciences, Inc. leads on 17 and Dr. Reddy's Laboratories Ltd on 5.
Valuation
Profitability
| Metric | NBIX | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.94% | 50.00% | 53.94% |
| Operating margin | 23.56% | 10.91% | 0.00% |
| Net margin | 20.91% | 9.81% | 0.00% |
| Free cash flow margin | 25.80% | 4.05% | 0.00% |
| Return on equity | 22.09% | 8.21% | (0.40%) |
| Return on assets | 15.26% | 5.55% | (3.32%) |
| Return on invested capital | 15.04% | 5.89% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack